DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 34 filers reported holding DEXCOM INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $123,002,161 | +10.2% | 39,416,000 | 0.0% | 7.61% | +3.4% |
| Q1 2023 | $111,572,112 | +2.7% | 39,416,000 | 0.0% | 7.36% | +19.7% |
| Q4 2022 | $108,683,471 | +39.5% | 39,416,000 | 0.0% | 6.15% | +67.9% |
| Q3 2022 | $77,888,000 | +1.8% | 39,416,000 | -4.8% | 3.66% | +17.5% |
| Q2 2022 | $76,475,000 | -40.7% | 41,416,000 | 0.0% | 3.12% | -33.2% |
| Q1 2022 | $128,868,000 | +1.3% | 41,416,000 | +6.4% | 4.67% | +3.2% |
| Q4 2021 | $127,201,000 | -1.7% | 38,916,000 | 0.0% | 4.52% | -17.9% |
| Q3 2021 | $129,442,000 | +27.8% | 38,916,000 | 0.0% | 5.51% | +31.4% |
| Q2 2021 | $101,257,000 | +35.2% | 38,916,000 | +14.7% | 4.19% | +36.1% |
| Q1 2021 | $74,894,000 | +1.6% | 33,916,000 | +4.6% | 3.08% | +9.1% |
| Q4 2020 | $73,730,000 | +65.7% | 32,416,000 | +84.3% | 2.82% | +34.3% |
| Q3 2020 | $44,493,000 | +194.2% | 17,584,000 | +189.0% | 2.10% | +145.4% |
| Q2 2020 | $15,125,000 | +11.0% | 6,084,000 | -22.4% | 0.86% | -20.3% |
| Q1 2020 | $13,620,000 | – | 7,838,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |